Prostate Cancer News

Biden, aides project optimism in cancer fight, but some close friends worry - The Washington Post

Biden, aides project optimism in cancer fight, but some close friends worry The Washington Post

‘The perfect partner’: Astellas, Vir engage in $1.7B deal for masked prostate cancer bispecific - Fierce Biotech

‘The perfect partner’: Astellas, Vir engage in $1.7B deal for masked prostate cancer bispecific Fierce Biotech

Microplastics found in prostate tumors in small study - NBC News

Microplastics found in prostate tumors in small study NBC News

Bayer sues J&J over 'false and misleading claims' about competing prostate cancer treatments - statnews.com

Bayer sues J&J over 'false and misleading claims' about competing prostate cancer treatments statnews.com

Which Type of Prostate Cancer ADT Is Safer for the Heart? - Medscape

Which Type of Prostate Cancer ADT Is Safer for the Heart? Medscape

Prostate cancer tumors have more than twice as much of this pollutant as healthy tissue: study - New York Post

Prostate cancer tumors have more than twice as much of this pollutant as healthy tissue: study New York Post

90% of Prostate Cancer Tumors Contained Microplastics - SciTechDaily

90% of Prostate Cancer Tumors Contained Microplastics SciTechDaily

Prostate cancer committee ‘exaggerated screening risks’ - The Telegraph

Prostate cancer committee ‘exaggerated screening risks’ The Telegraph

Bayer sues Johnson & Johnson over claim that prostate cancer drug cuts risk of death - Reuters

Bayer sues Johnson & Johnson over claim that prostate cancer drug cuts risk of death Reuters

Microplastics found in higher levels in prostate tumor tissue: Research - The Hill

Microplastics found in higher levels in prostate tumor tissue: Research The Hill

Microplastics Found in 90 Percent of Prostate Cancer Samples - The ASCO Post

Microplastics Found in 90 Percent of Prostate Cancer Samples The ASCO Post

Exploring the Role of Actinium-225 in Metastatic Castration-Resistant Prostate Cancer - Targeted Oncology

Exploring the Role of Actinium-225 in Metastatic Castration-Resistant Prostate Cancer Targeted Oncology

Survival trend in metastatic prostate cancer two decades of real-world data on overall survival from Germany - Nature

Survival trend in metastatic prostate cancer two decades of real-world data on overall survival from Germany Nature

Microplastics Discovered in Prostate Tumors - NYU Langone Health

Microplastics Discovered in Prostate Tumors NYU Langone Health

Prostate Cancer: New treatments and new options - KPLC 7 News

Prostate Cancer: New treatments and new options KPLC 7 News

How to Date After a Prostate Cancer Diagnosis - Everyday Health

How to Date After a Prostate Cancer Diagnosis Everyday Health

New real‑world data reinforce earlier use of Pluvicto® before chemotherapy in metastatic castration-resistant prostate cancer - Novartis

New real‑world data reinforce earlier use of Pluvicto® before chemotherapy in metastatic castration-resistant prostate cancer Novartis

Bayer Accuses J&J of Misleading Ads for Its Prostate-Cancer Drug - Bloomberg

Bayer Accuses J&J of Misleading Ads for Its Prostate-Cancer Drug Bloomberg

Leuprolide Tied to More Coronary Plaque in Prostate Cancer Progression - EMJ | Elevating the quality of healthcare globally

Leuprolide Tied to More Coronary Plaque in Prostate Cancer Progression EMJ | Elevating the quality of healthcare globally

This Small-Cap Biotech Stock Is Soaring 29%. There’s Excitement Over Its Prostate Cancer Drug. - Barron's

This Small-Cap Biotech Stock Is Soaring 29%. There’s Excitement Over Its Prostate Cancer Drug. Barron's

Vir climbs on Astellas deal, study results for ‘masked’ T cell engager - BioPharma Dive

Vir climbs on Astellas deal, study results for ‘masked’ T cell engager BioPharma Dive

Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer - BioSpace

Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer BioSpace

K36 Therapeutics Highlights First-in-Human KTX-2001 Prostate Cancer Study Design at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2026 - PR Newswire

K36 Therapeutics Highlights First-in-Human KTX-2001 Prostate Cancer Study Design at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2026 PR Newswire

The Prostate Cancer Foundation Receives $10 Million Gift, Announces TACTICAL Award to Fuel Research on - Business Wire

The Prostate Cancer Foundation Receives $10 Million Gift, Announces TACTICAL Award to Fuel Research on Business Wire

Monte Rosa shares rise on prostate cancer trial results - Investing.com

Monte Rosa shares rise on prostate cancer trial results Investing.com

ASCO’s First Living Guideline in GU Cancers Reflects Recent Practice-Changing Trials on Systemic Treatment of mCRPC - The ASCO Post

ASCO’s First Living Guideline in GU Cancers Reflects Recent Practice-Changing Trials on Systemic Treatment of mCRPC The ASCO Post

Missing the full picture: Pathology, anatomy, and operator effects in HoLEP comparisons - Nature

Missing the full picture: Pathology, anatomy, and operator effects in HoLEP comparisons Nature

Survivor Runs First Marathon to Fund Prostate Cancer Research - Prostate Cancer Foundation (PCF)

Survivor Runs First Marathon to Fund Prostate Cancer Research Prostate Cancer Foundation (PCF)

Men With Learning Disabilities Experience Worse Prostate Cancer Outcomes - CancerNetwork

Men With Learning Disabilities Experience Worse Prostate Cancer Outcomes CancerNetwork

Experts Preview Practice-Changing Data Ahead of 2026 ASCO GU - CUREtoday.com

Experts Preview Practice-Changing Data Ahead of 2026 ASCO GU CUREtoday.com

Incorporating Bone-Protecting Agents in Prostate Cancer Guidelines - Targeted Oncology

Incorporating Bone-Protecting Agents in Prostate Cancer Guidelines Targeted Oncology

Vir's masked prostate cancer T-cell engager draws $1.7B commitment from Astellas - FirstWord Pharma

Vir's masked prostate cancer T-cell engager draws $1.7B commitment from Astellas FirstWord Pharma

Vir Biotech Soars On Global Collaboration With Astellas, Encouraging Prostate Cancer Drug Data - Nasdaq

Vir Biotech Soars On Global Collaboration With Astellas, Encouraging Prostate Cancer Drug Data Nasdaq

A landmark 'evolutionary double-bind' strategy to overcome treatment resistance in prostate cancer - Medical Xpress

A landmark 'evolutionary double-bind' strategy to overcome treatment resistance in prostate cancer Medical Xpress

Letter: The Hawthorne effect—behavioral changes from research observation—as confounder and mediator in the ERASE trial - Nature

Letter: The Hawthorne effect—behavioral changes from research observation—as confounder and mediator in the ERASE trial Nature

Prostate Cancer: New treatments and new options - KPLC 7 News

Prostate Cancer: New treatments and new options KPLC 7 News

MiraDx Launches New Genetic Test Expanding Radiation Therapy Risk Assessment for Prostate Cancer Patients - Business Wire

MiraDx Launches New Genetic Test Expanding Radiation Therapy Risk Assessment for Prostate Cancer Patients Business Wire